FeNO testing helps physicians identify the magnitude and extent of allergic airway inflammation in patients with COPD and asthma. Data provides important implications for management of COPD patients with Overlap Syndrome

SOLNA, Sweden, Morrisville, North Carolina– 20 May, 2013 - Aerocrine AB (OMX Nordic Exchange: AERO) ---Aerocrine today announced the following  scientific abstract, Characterization of Allergic Airway Inflammation in Patients with COPD using Fractional exhaled Nitric Oxide Level (FeNO) s, presented at the 2013 American Thoracic Society International Conference. The abstract was presented by Dr. James F. Donohue, principle investigator for the study at (American Thoracic Society meeting in Philadelphia) on (Sunday May 19, 2013).
Asthma can coexist with chronic obstructive pulmonary disease (COPD), particularly in older adults, a condition labeled overlap syndrome. While airway inflammation in COPD is largely neutrophilic, some patients with COPD may have features...